News from the BioCity Campus

7 in one fell swoop – MEDICAL FORGE LEIPZIG starts a new round

MEDICAL FORGE Leipzig, an accelerator for young innovative medical technology companies on the BioCity Campus Leipzig, facilitates entry into the German healthcare market and brings seven international start-ups to Saxony.

After a successful start in 2022 with 8 international startups, MEDICAL FORGE Leipzig - Accelerator for Medical Devices and Therapies is entering the second round. Seven teams
are supported in the 12-month program on their way into the German healthcare market and benefit from the cooperation with the local innovation ecosystem in the healthcare sector.
The structural change project - funded by the Federal Ministry of Economics and Climate Protection - aims to create long-term jobs in Leipzig and in the central German district
and to further strengthen Leipzig as a business location, particularly in the field of life sciences.
On the one hand, MEDICAL FORGE offers fully equipped biochemistry laboratories, a 3D printer and electronics workstations in BIO CITY LEIPZIG, on the other hand, the teams in the areas of regulatory affairs, market access and business development are coached. During the Welcome Week (03.04/07.04.2023/XNUMX to XNUMX/XNUMX/XNUMX) the teams not only got to know each other, but also discovered a lot of interesting facts about the city of Leipzig on a city tour. Tuesday was all about networking. In a "World Café" format, the teams had the opportunity to meet the partners of MEDICAL FORGE, similar to speed dating. The Leipzig University Hospital, the Sankt Georg Leipzig Hospital and Luther were among the participants
Lawyers, PROMEGA, the Office for Economic Development of the City of Leipzig and the Saxony Economic Development Agency. At the network party that followed, the teams exchanged ideas
in a relaxed atmosphere with the partners and the BIO CITY community. Individual meetings are planned on Wednesday, April 05.04.2023th, XNUMX to initiate initial cooperation.
“The number of applicants has tripled compared to the first round. The accelerator program itself as well as the Leipzig location are perceived internationally.”, says happily
Simone Haubner, COO of MEDICAL FORGE.

2nd round teams:
ZuriMed (Switzerland) introduces the FiberLocker System to revolutionize soft tissue repair in orthopedics and sports medicine (plaster grafts).
SDS Optic (Poland) has developed a microprobe for real-time diagnosis of breast cancer. Breast cancer is the most common cancer in women and the second most common cancer
in total.
The Team of MUVON Therapeutics (Switzerland) is pursuing the goal of developing the world's first commercially viable and clinically relevant regenerative cell-based therapy for the treatment of diseases caused by muscle breakdown with one device. The initial focus is on treating Stress Urinary Incontinence (SUI), which affects over 200 million people worldwide.
NeuroTrigger (Israel) is aiming to enter the German market with a wearable eyelid pacemaker that enables people with total or partial facial paralysis to blink

Microx Sp Zo. O. (USA/Poland) has developed a remote monitoring product consisting of a set of disposable cartridges and a cloud-connected CBC (blood count) and protein (CRP, PCT and IL-6) measurement device to enable doctors to to classify immunocompromised patients or patients undergoing chemotherapy into mild, moderate and severe cases.
Glycanostics sro (Slovakia) has developed a highly accurate and unique cancer diagnostic test based on the analysis of glycans in blood serum and early diagnosis
allows. This patented technology covers the possible diagnosis of eleven types of cancer.

MEDICAL FORGE Leipzig by biosaxony supports startups and innovative SMEs in bringing their medical devices to the German healthcare market faster. The 12 month
Accelerator program focuses on industry-specific issues such as approval, marketing, reimbursement and clinical evidence. Through individual coaching and mentoring
as well as a market-specific training offer, selected start-ups are supported in further developing their software solutions and devices into finished medical products and in the
to implement in clinical settings. Together with partners from industry, health insurance companies and clinics, the founders will continue to forge their products and services in order to bring them to market maturity.
The program is funded by the Federal Ministry of Economics and Climate Protection based on a decision by the German Bundestag.

About biosaxony
biosaxony is the all-Saxon association for biotechnology, medical technology and healthcare. Its members include companies, scientific institutions as well
Industry stakeholders and suppliers. The network is supplemented by representatives of the user side, for example clinics and health insurance companies. The network combines forces
of all member companies and represents their interests in politics and the public. The tasks of the cluster include the initiation of projects between business and science,
the provision of services and know-how as well as the presentation of regional competencies in order to support the value-adding expansion of these cross-sectional technologies and to strengthen the economic region of Saxony. In addition, the promotion of young innovative companies is one of the main concerns of the network.

Source: Press Release biosaxony by 5.4.2023

previous news

Saventic: platform for diagnosing rare diseases

Saventic Health GmbH has launched a patient platform that aims to speed up the diagnosis of rare diseases. The medical expert committee of the medtech company uses its own expertise as well as AI-supported decision-making tools.


After work free beer: again on April 12.04th!

Come to network with colleagues from the BioCity Campus. Casual, cordial, informative